GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (OTCPK:IPSEY) » Definitions » Other Gross PPE

Ipsen (IPSEY) Other Gross PPE : $627 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Ipsen Other Gross PPE?

Ipsen's Other Gross PPE for the quarter that ended in Dec. 2023 was $627 Mil.

Ipsen's quarterly Other Gross PPE increased from Dec. 2022 ($456 Mil) to Jun. 2023 ($482 Mil) and increased from Jun. 2023 ($482 Mil) to Dec. 2023 ($627 Mil).

Ipsen's annual Other Gross PPE declined from Dec. 2021 ($638 Mil) to Dec. 2022 ($456 Mil) but then increased from Dec. 2022 ($456 Mil) to Dec. 2023 ($627 Mil).


Ipsen Other Gross PPE Historical Data

The historical data trend for Ipsen's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipsen Other Gross PPE Chart

Ipsen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 561.33 646.96 637.51 456.14 626.61

Ipsen Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 637.51 462.69 456.14 482.45 626.61

Ipsen Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Ipsen (IPSEY) Business Description

Traded in Other Exchanges
Address
65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.